GI Permeability Change in Response to Aquamin®

Exclusion Criteria

• •Must not be pregnant or lactating
• •Must not be participating in any other interventional trial using an investigational drug.
• •Subjects likely to be uncooperative or unable to comply with study procedures
• •Participants must not be felt to have active ulcerative colitis for 3 months before study enrollment (with an exception of mild ulcerative colitis).
• •Participants must not have a history or diagnosis of any of the following conditions:
• •Crohn's disease, Any stomach or intestinal bleeding disorders (gastrointestinal bleeding from gastric or duodenal ulcers, or gastrin secreting tumors) or active gastric/duodenal ulcers - peptic ulcer disease (without bleeding in last 3 months).
• •Must not have any gastrointestinal or colonic malignancy.
• •Must not have Kidney disease, including kidney "stones" or hypercalcemia.
• •Must not have Coagulopathy/hereditary hemorrhagic disorders
• •Participants will be excluded if they have taken certain medications (per protocol), within the last 30 days or are unwilling to forgo the following for 30 days prior to entry into the study.
• •Must not be pregnant or lactating.
• •Must not be participating in any other interventional trial using an investigational drug.
• •Participants must not have a history or diagnosis of any of the following conditions:
• •Kidney disease, including kidney "stones" or hypercalcemia, Crohn's disease, Neurologic disease, other inflammatory bowel disease, any stomach or intestinal bleeding disorders (gastrointestinal bleeding from gastric or duodenal ulcers, or gastrin secreting tumors) or active gastric/duodenal ulcers - peptic ulcer disease (without bleeding in last 3 months).
• •Not have Coagulopathy/hereditary hemorrhagic disorders
• •Any gastrointestinal or colonic malignancy.
• •Participants will be excluded if they have taken certain medications (per protocol), within the last 30 days or are unwilling to forgo the following for 30 days prior to entry into the study.
• •Must not be pregnant or lactating
• •Must not be participating in any other interventional trial using an investigational drug.
• •Participants must not have a history or diagnosis of Crohn's disease or Inflammatory bowel disease, any stomach or intestinal bleeding disorders (gastrointestinal bleeding from gastric or duodenal ulcers, or gastrin secreting tumors) or active gastric / duodenal ulcers - peptic ulcer disease (without bleeding in last 3 months).
• •Must not have any gastrointestinal or colonic malignancy.
• •Must not have kidney disease, including kidney "stones" or hypercalcemia, Coagulopathy/hereditary hemorrhagic disorders, neurologic disease
• •Participants will be excluded if they have taken certain medications (per protocol), within the last 30 days or are unwilling to forgo the following for 30 days prior to entry into the study.